Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marlene, Drag"'
Autor:
Aliénor Delsart, Colombe Otis, Vivian S. Y. Leung, Émilie Labelle, Maxim Moreau, Marilyn Frezier, Marlene Drag, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Eric Troncy
Publikováno v:
Animals, Vol 14, Iss 5, p 711 (2024)
Veterinarians face the lack of a rapid, reliable, inexpensive, and treatment-sensitive metrological instrument reflecting feline osteoarthritis (OA) pain. The Montreal Instrument for Cat Arthritis Testing, for Use by Veterinarians (MI-CAT(V)) has bee
Externí odkaz:
https://doaj.org/article/e3599958e241467f88782507626b3ee5
Autor:
Aliénor Delsart, Maxim Moreau, Colombe Otis, Marilyn Frezier, Marlene Drag, Jean-Pierre Pelletier, Johanne Martel-Pelletier, Bertrand Lussier, Jérôme del Castillo, Eric Troncy
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 11780
The metrological properties of two performance-based outcome measures of feline osteoarthritis (OA), namely Effort Path (Path) and Stairs Assay Compliance (Stairs), were tested. Cats naturally affected by OA (n = 32) were randomly distributed into fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbb7ccb098536bba8ee9b62d74f5878
https://pubmed.ncbi.nlm.nih.gov/36233085
https://pubmed.ncbi.nlm.nih.gov/36233085
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 45(4)
Afoxolaner, an insecticide and acaricide compound of the isoxazoline class, is available for dogs as an oral ectoparasiticide medicine (NexGard®) and as an oral endectoparasiticide medicine in combination with milbemycin oxime (MO), a macrocyclic la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07744987704e40daf87f2b0efcff19af
https://pubmed.ncbi.nlm.nih.gov/35536118
https://pubmed.ncbi.nlm.nih.gov/35536118
Autor:
Elizabeth B. Mitchell, Diane Larsen, Marlene Drag, S.T. Chester, J.W. McCall, Christine F. Baker, S.D. McCall
Publikováno v:
Comparative Immunology, Microbiology and Infectious Diseases. 49:65-69
A randomized, blinded, negative controlled study was conducted to determine whether treatment with afoxolaner (NexGard®, Merial, Inc.) would prevent the transmission of Borrelia burgdorferi to dogs by wild caught Ixodes scapularis ticks. Twenty heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d69fd15080cd9a5d5a2403b94aeacc
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 40:447-453
The safety profile of afoxolaner (an isoxazoline molecule) when combined with milbemycin oxime (a macrocyclic lactone) was evaluated according to the regulatory requirements when administered six times orally in a soft chewable formulation at a dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::958b4741913bbe6fccfe532d659f99f2
https://doi.org/10.1111/jvp.12375
https://doi.org/10.1111/jvp.12375
Publikováno v:
Veterinary Parasitology. 201(3-4):198-203
The safety profile of afoxolaner, a new isoxazoline molecule, was evaluated following the regulatory requirements when administered six times orally in a soft chewable formulation at a dose of at least 1×, 3× or 5× the maximum exposure dose (6.3mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803760994ae98860fb33a6befb3a1570
Publikováno v:
Veterinary Parasitology. 201(3-4):190-197
The pharmacokinetics of afoxolaner in dogs was evaluated following either intravenous or after oral administration of NEXGARD(®), a soft chewable formulation. Afoxolaner is a member of one of the newest classes of antiparasitic agents, known as anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f92fc5b5b78887e9fdd46a8becb7038
Publikováno v:
Veterinary Parasitology. 201:226-228
Two studies were conducted to confirm that a single oral dose of the novel insecticide/acaricide afoxolaner is efficacious against existing infestations of Rhipicephalus sanguineus sensu lato in dogs and can control re-infestation for up to 35 days.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05200036d2fdba5ee95ad0dc68cd453e
https://doi.org/10.1016/j.vetpar.2014.02.018
https://doi.org/10.1016/j.vetpar.2014.02.018
Publikováno v:
Veterinary Parasitology. 201(3-4):204-206
The speed of kill of afoxolaner against experimental infestations by Ctenocephalides felis was evaluated after oral administration of afoxolaner in a soft chew (NEXGARD®) at a dose to achieve 2.5mg/kg bodyweight. Forty beagles were allocated to two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9aef2cdb79740a8ae6c9ba6604e05e4
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 40(1)
The pharmacokinetics of afoxolaner and milbemycin oxime (A3 and A4 forms) in dogs were evaluated following the oral administration of NexGard Spectra® (Merial), a fixed combination chewable formulation of these two active pharmaceutical ingredients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1590597c498c7bee2fa7a9d8ed1a23d8
https://pubmed.ncbi.nlm.nih.gov/27604405
https://pubmed.ncbi.nlm.nih.gov/27604405